In Vitro Diagnostic Estradiol Test Recalled for Falsely Elevated Results
Siemens Healthcare Diagnostics is recalling Atellica IM Enhanced Estradiol (eE2) 500T diagnostic kits that produce falsely elevated test results in plasma specimens, which could lead clinicians to misinterpret patient results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II medical device recall involving a risk-of-harm product (diagnostic test producing incorrect results that could lead to clinical misinterpretation and potential harm) with no reported injuries. Per the severity rubric, risk-of-harm products where injury has not yet been reported qualify as High (3).
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling all lots of Atellica IM Enhanced Estradiol (eE2) 500T, an in vitro diagnostic test kit used to measure estradiol levels in blood plasma. The recall is due to falsely elevated test results observed in plasma specimens, which could lead clinicians to misinterpret patient results.
The affected product has been distributed worldwide, including throughout the United States and to countries including Austria, Belgium, Brazil, France, India, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, and the United Kingdom, among others. A total of 374 units are affected.
Healthcare providers and facilities using the Atellica IM Enhanced Estradiol (eE2) 500T should verify that they have affected units by checking their lot numbers against the UDI codes listed in the FDA recall notice. Affected lots should be removed from service. Facilities should contact Siemens Healthcare Diagnostics for instructions regarding device returns and replacement options.
The recalled product
- Product
- Atellica IM Enhanced Estradiol (eE2) 500T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10995562 All lots
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Hazard
- Affected units
- 374
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · inaccurate results
See all →- HighHealthmark Protein Test Recalled Due to Expired Ingredient
FDA (Devices) · 2026-09-02
- HighHardyDisk AST Cefiderocol 30µg for In Vitro Testing Recalled Due to Incorrect Cartridges
FDA (Devices) · 2026-08-12
- HighGEM Premier 7000 with iQM3 Blood Analysis Systems Recalled for Solution Concentration Issues
FDA (Devices) · 2026-08-12
- Highepoc BGEM BUN Test Card for epoc Blood Analysis System
FDA (Devices) · 2026-05-06
- HighAbbott i-STAT EG7+ Blood Gas Cartridges Reporting Inaccurate Results
FDA (Devices) · 2026-05-06